These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1741765)

  • 1. Cytosol mediated metabolism of the experimental antitumor agent acridine carboxamide to the 9-acridone derivative.
    Robertson IG; Palmer BD; Officer M; Siegers DJ; Paxton JW; Shaw GJ
    Biochem Pharmacol; 1991 Oct; 42(10):1879-84. PubMed ID: 1741765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by SKF-525A of the aldehyde oxidase-mediated metabolism of the experimental antitumour agent acridine carboxamide.
    Robertson IG; Bland TJ
    Biochem Pharmacol; 1993 May; 45(10):2159-62. PubMed ID: 8512597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat hepatocyte-mediated metabolism of the experimental anti-tumour agent N-[2'-(dimethylamino)ethyl]acridine-4-carboxamide.
    Schlemper B; Siegers DJ; Paxton JW; Robertson IG
    Xenobiotica; 1993 Apr; 23(4):361-71. PubMed ID: 8337894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the experimental antitumor agent acridine carboxamide in the mouse.
    Robertson IG; Palmer BD; Paxton JW; Bland TJ
    Drug Metab Dispos; 1993; 21(3):530-6. PubMed ID: 8100511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-species variation in the metabolism and inhibition of N-[(2'-dimethylamino)ethyl]acridine-4-carboxamide (DACA) by aldehyde oxidase.
    Schofield PC; Robertson IG; Paxton JW
    Biochem Pharmacol; 2000 Jan; 59(2):161-5. PubMed ID: 10810450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the blood-brain barrier and liver penetration of acridine antitumor drugs.
    Cornford EM; Young D; Paxton JW
    Cancer Chemother Pharmacol; 1992; 29(6):439-44. PubMed ID: 1568286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide towards Lewis lung carcinoma and human tumour cell lines in vitro.
    Finlay GJ; Baguley BC
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):271-7. PubMed ID: 2702982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trial.
    Schofield PC; Robertson IG; Paxton JW; McCrystal MR; Evans BD; Kestell P; Baguley BC
    Cancer Chemother Pharmacol; 1999; 44(1):51-8. PubMed ID: 10367749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual dynamics of killing of cultured Lewis lung cells by the DNA-intercalating antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
    Haldane A; Finlay GJ; Gavin JB; Baguley BC
    Cancer Chemother Pharmacol; 1992; 29(6):475-9. PubMed ID: 1568291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photo-enhancement of the mutagenicity of 9-anilinoacridine derivatives related to the antitumour agent amsacrine.
    Iwamoto Y; Ferguson LR; Pearson A; Baguley BC
    Mutat Res; 1992 Jul; 268(1):35-41. PubMed ID: 1378184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
    Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
    J Med Chem; 1987 Apr; 30(4):664-9. PubMed ID: 3560161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal administration of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in the mouse: bioavailability, pharmacokinetics and toxicity after a single dose.
    Evans SM; Young D; Robertson IG; Paxton JW
    Cancer Chemother Pharmacol; 1992; 31(1):32-6. PubMed ID: 1458557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues.
    Osman S; Rowlinson-Busza G; Luthra SK; Aboagye EO; Brown GD; Brady F; Myers R; Gamage SA; Denny WA; Baguley BC; Price PM
    Cancer Res; 2001 Apr; 61(7):2935-44. PubMed ID: 11306471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of acridine by rat-liver enzymes.
    McMurtrey KD; Knight TJ
    Mutat Res; 1984 May; 140(1):7-11. PubMed ID: 6738572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2.
    Adams A; Guss JM; Collyer CA; Denny WA; Wakelin LP
    Biochemistry; 1999 Jul; 38(29):9221-33. PubMed ID: 10413496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic and DNA-damaging properties of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and its analogues.
    Pastwa E; Ciesielska E; Piestrzeniewicz MK; Denny WA; Gniazdowski M; Szmigiero L
    Biochem Pharmacol; 1998 Aug; 56(3):351-9. PubMed ID: 9744573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and toxicity of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide after i.v. administration in the mouse.
    Paxton JW; Young D; Evans SM; Kestell P; Robertson IG; Cornford EM
    Cancer Chemother Pharmacol; 1992; 29(5):379-84. PubMed ID: 1551177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro binding of metabolically activated [14C]-ledakrin, or 1-nitro-9-14C-(3'-dimethylamino-N-propylamino) acridine, a new antitumor and DNA cross-linking agent, to macromolecules of subcellular fractions isolated from rat liver and HeLa cells.
    Pawlak JW; Konopa J
    Biochem Pharmacol; 1979 Dec; 28(23):3391-402. PubMed ID: 43732
    [No Abstract]   [Full Text] [Related]  

  • 19. Methadone: a potent inhibitor of rat liver aldehyde oxidase.
    Robertson IG; Gamage RS
    Biochem Pharmacol; 1994 Feb; 47(3):584-7. PubMed ID: 8117328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of conjugation and cleavage products in the thiolytic metabolism of the anticancer drug 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Przybylski M; Cysyk RL; Shoemaker D; Adamson RH
    Biomed Mass Spectrom; 1981 Oct; 8(10):485-91. PubMed ID: 6895335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.